Poly (ADP-ribose) polymerase 14 and its enzyme activity regulates TH2 differentiation and allergic airway disease

PARP-14 and the catalytic activity associated with it promote TH2 differentiation and AAD in a murine model, and targeting PARP-14 might be a potential new therapy for allergic asthma.